后抗生素时代是全球卫生保健面临的挑战:该怎么办?

Asad U. Khan
{"title":"后抗生素时代是全球卫生保健面临的挑战:该怎么办?","authors":"Asad U. Khan","doi":"10.4172/Clinical-Investigation.1000109","DOIUrl":null,"url":null,"abstract":"Medical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, A.M.U, Aligarh 202002 India *Author for correspondence: asad.k@rediffmail.com Submitted Date: 12-May-2017 Accepted Date: 16-May-2017 Published Date: 19-May-2017 Letter to Editor In this 21st century, antibiotics are almost worn out due to global antibiotic resistance scenario. It has become a worldwide concern to cope with the existing situation, where, even last resorts of antibiotics are not effective against common infections. After the discovery of New-Delhi Metallo β-lactamase-1 (NDM-1) and its variants, evolving mutants, it is becoming difficult to use any β-lactam antibiotics, even carbapenems. Moreover, the use of colistin/polymyxin was one of the optimism to control such infections but MCR-1 discovery has turned down that prospect. Antibiotic resistance has now been recognized as serious global menace of 21st century to the mankind. Therefore, WHO has declared it as the priority research area and a “Global Action plan on antibiotic resistance” has already been launched to prevent this disaster taking to pre-antibiotic era.","PeriodicalId":10369,"journal":{"name":"Clinical investigation","volume":"7 1","pages":"41"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Post-antibiotic era is a worldwide challenge for health care: what to do ?\",\"authors\":\"Asad U. Khan\",\"doi\":\"10.4172/Clinical-Investigation.1000109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, A.M.U, Aligarh 202002 India *Author for correspondence: asad.k@rediffmail.com Submitted Date: 12-May-2017 Accepted Date: 16-May-2017 Published Date: 19-May-2017 Letter to Editor In this 21st century, antibiotics are almost worn out due to global antibiotic resistance scenario. It has become a worldwide concern to cope with the existing situation, where, even last resorts of antibiotics are not effective against common infections. After the discovery of New-Delhi Metallo β-lactamase-1 (NDM-1) and its variants, evolving mutants, it is becoming difficult to use any β-lactam antibiotics, even carbapenems. Moreover, the use of colistin/polymyxin was one of the optimism to control such infections but MCR-1 discovery has turned down that prospect. Antibiotic resistance has now been recognized as serious global menace of 21st century to the mankind. Therefore, WHO has declared it as the priority research area and a “Global Action plan on antibiotic resistance” has already been launched to prevent this disaster taking to pre-antibiotic era.\",\"PeriodicalId\":10369,\"journal\":{\"name\":\"Clinical investigation\",\"volume\":\"7 1\",\"pages\":\"41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/Clinical-Investigation.1000109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/Clinical-Investigation.1000109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

医学微生物学和分子生物学实验室,跨学科生物技术股,A.M.U, Aligarh 2002印度*通讯作者:asad.k@rediffmail.com提交日期:2017年5月12日接受日期:2017年5月16日发表日期:2017年5月19日致编辑信在21世纪,由于全球抗生素耐药性的情况,抗生素几乎被耗尽。在这种情况下,即使是最后的抗生素手段也不能有效地对抗常见的感染,如何应对这种情况已成为全世界关注的问题。在发现新德里金属β-内酰胺酶-1 (NDM-1)及其变体、进化突变体之后,使用任何β-内酰胺类抗生素,甚至碳青霉烯类抗生素都变得越来越困难。此外,使用粘菌素/多粘菌素是控制此类感染的乐观因素之一,但MCR-1的发现使这一前景变得黯淡。抗生素耐药性已被公认为21世纪人类面临的严重全球性威胁。因此,世卫组织已宣布其为重点研究领域,并已启动“抗生素耐药性全球行动计划”,以防止这一灾难回到抗生素前时代。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Medical Microbiology and Molecular Biology Laboratory, Interdisciplinary Biotechnology Unit, A.M.U, Aligarh 202002 India *Author for correspondence: asad.k@rediffmail.com Submitted Date: 12-May-2017 Accepted Date: 16-May-2017 Published Date: 19-May-2017 Letter to Editor In this 21st century, antibiotics are almost worn out due to global antibiotic resistance scenario. It has become a worldwide concern to cope with the existing situation, where, even last resorts of antibiotics are not effective against common infections. After the discovery of New-Delhi Metallo β-lactamase-1 (NDM-1) and its variants, evolving mutants, it is becoming difficult to use any β-lactam antibiotics, even carbapenems. Moreover, the use of colistin/polymyxin was one of the optimism to control such infections but MCR-1 discovery has turned down that prospect. Antibiotic resistance has now been recognized as serious global menace of 21st century to the mankind. Therefore, WHO has declared it as the priority research area and a “Global Action plan on antibiotic resistance” has already been launched to prevent this disaster taking to pre-antibiotic era.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Targeting TGF-beta pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19 A Prospective on Allergic Rhinitis Use of Cladribine for multiple sclerosis treatment: An image article Thalidomide may be an effective medicine for Blau Syndrome Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1